Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for rev...
Daiichi Sankyo has announced the launch in Japan of MINNEBRO® Tablets 1.25 mg, 2.5 mg and 5 mg (generic name: e...
Eisai Co., Ltd. has entered into a license agreement with medac Gesellschaft für klinische Spezialpräparate mb...
Japan headquartered Takeda Pharma has entered into an agreement to sell TachoSil®, a surgical patch designed to achi...
Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the asset...
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...
Promethera Biosciences, a global innovator in cell-based medicines and liver diseases has announced the closing of a &eu...
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...
Eisai Co., Ltd. and the UK Dementia Research Institute (UK DRI) announced the launch of a joint post-doctoral programme ...
US based Skyhawk Therapeutics, Inc. has announced a strategic collaboration with Japan headquartered Takeda Pharmaceutic...
Takeda has announced the opening of a new research facility in San Diego, California. Extending Takeda’s 14-year p...
Global biopharmaceutical company Takeda announced Andrey Potapov as its Area Head for India, CIS (the Commonwealth of In...
Researchers at Okayama University in Japan have reported in the journal Sensors and Actuators B: Chemical that terahertz...
Santen and Glaukos have announced that Santen’s U.S. subsidiary, Santen Inc., has entered into a multi-year agreem...
Zymeworks Inc. a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, and Daiichi Sankyo...
Daiichi Sankyo Company LTD. (Daiichi Sankyo), dedicated to the creation and supply of innovative pharmaceutical products...
Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the pre...
Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, announced that it has ent...
